Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.48 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.48 |
| ▸ | FBP1 | P09467 | 1/20 | 0.48 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.48 |
| ▸ | DRD2 | P14416 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.48 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.48 |
| ▸ | DRD1 | P21728 | 1/20 | 0.48 |
| ▸ | MC5R | P33032 | 1/20 | 0.48 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.48 |
| ▸ | DRD3 | P35462 | 1/20 | 0.48 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.48 |
| ▸ | CCR2 | P41597 | 1/20 | 0.48 |
| ▸ | HTR6 | P50406 | 1/20 | 0.48 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.48 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30938811 | 0.79 | PSMB8 (0.53) | IDO1ALDH1A1HSD17B10ADRA2AFBP1 | |
| SCHEMBL29800442 | 0.79 | IDO1 (0.50) | IDO1ALDH1A1HSD17B10ADRA2AFBP1 | |
| SCHEMBL221981 | 0.79 | ALDH1A1 (0.51) | IDO1ALDH1A1HSD17B10ADRA2AFBP1 | |
| SCHEMBL3096380 | 0.79 | IDO1 (0.50) | IDO1ALDH1A1HSD17B10ADRA2AFBP1 | |
| SCHEMBL719079 | 0.79 | IDO1 (0.50) | IDO1ALDH1A1HSD17B10ADRA2AFBP1 | |
| SCHEMBL15874315 | 0.79 | IDO1 (0.50) | IDO1ALDH1A1HSD17B10ADRA2AFBP1 | |
| SCHEMBL492446 | 0.79 | PSMB8 (0.53) | IDO1ALDH1A1HSD17B10ADRA2AFBP1 | |
| SCHEMBL1436096 | 0.78 | IDO1 (0.48) | IDO1ALDH1A1HSD17B10ADRA2AFBP1 | |
| SCHEMBL9187493 | 0.73 | IDO1 (0.44) | IDO1ALDH1A1HSD17B10ADRA2AFBP1 | |
| SCHEMBL6002818 | 0.72 | IDO1 (0.43) | IDO1ALDH1A1HSD17B10ADRA2AFBP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7358403-B2 | Chiral sensor | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2008-04-15 | — | — | US | disclosed |
| EP-1538148-B1 | CHIRAL SENSOR | JAPAN SCIENCE & TECH AGENCY (JP) | 2007-01-10 | — | — | EP | disclosed |
| US-20050227366-A1 | optically active compound having an unsaturated bond at an optically active binding site, wherein the unsaturated bond and a fluorescent substituent or a substituent capable of imparting fluorescence are united in a conjugated manner; capable of recognizing a chiral compound in a high sensitivity | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2005-10-13 | — | — | US | disclosed |
| EP-1538148-A1 | CHIRAL SENSOR | Japan Science and Technology Agency (JP) | 2005-06-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050227366-A1 | optically active compound having an unsaturated bond at an optically active binding site, wherein the unsaturated bond and a fluorescent substituent or a substituent capable of imparting fluorescence are united in a conjugated manner; capable of recognizing a chiral compound in a high sensitivity | FASN, DBI, SCD | IDO1 3755/4885ALDH1A1 304/4885HSD17B10 406/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.